STRF:NASDAQStrategy Inc - 10.00% Series A Perpetual Strife Preferred Stock Analysis
Data as of 2026-08-02 - not real-time
$94.76
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading just above its short‑term moving average but remains below the long‑term moving average, with the MACD line sitting under its signal line and a modestly negative histogram, suggesting bearish momentum. The RSI is hovering in the neutral zone, while price is perched near a recently identified support level and faces resistance a short distance higher. Volume has been on the rise, and market sentiment is marked by extreme greed, which can amplify short‑term price swings.
Fundamental outlook: Revenue is growing modestly, yet the company is posting massive operating losses, zero earnings per share, and negative profit margins. Debt is exceptionally high relative to equity, cash flow is flat, and the generous dividend yield is unlikely to be sustainable given the cash‑flow profile. The firm’s exposure to Bitcoin adds a layer of volatility and regulatory scrutiny, further complicating the outlook.
Fundamental outlook: Revenue is growing modestly, yet the company is posting massive operating losses, zero earnings per share, and negative profit margins. Debt is exceptionally high relative to equity, cash flow is flat, and the generous dividend yield is unlikely to be sustainable given the cash‑flow profile. The firm’s exposure to Bitcoin adds a layer of volatility and regulatory scrutiny, further complicating the outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- price hugging support
- bearish MACD momentum
- dividend appears unsustainable
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- bitcoin price pressure on financing
- high leverage and debt burden
- upcoming earnings release could clarify cash position
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- persistent negative cash flow
- regulatory uncertainty around crypto holdings
- ongoing strain on financing mechanisms
Key Metrics & Analysis
Financial Health
Revenue Growth6.90%
ROE-63.56%
ROA-38.73%
Debt/Equity14.94
P/B Ratio0.9
Industry P/E32.8
Technical Analysis
TrendNeutral
RSI45.9
Support$94.45
Resistance$98.50
MA 20$96.44
MA 50$95.49
MA 200$100.83
MACDBearish
VolumeIncreasing
Fear & Greed Index92.88
Valuation
GradeUndervalued
TypeValue
Dividend Yield10.53%
Risk Assessment
Beta0.73
Volatility35.93%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.